Showing results (271-280 of 1,048) with videos related to
Sort By:
Pageof 105
Neuroscience Applied|July 14, 2025
Mechanisms underlying anxiety in Rett Syndrome: Translational insights from preclinical findingsBethan Impey, Tracey A Newman, David S BaldwinSocial Psychiatry and Psychiatric Epidemiology|March 19, 2009
A cross-sectional study of mental health and well-being and their associations in the UK veterinary professionDavid J Bartram, Ghasem Yadegarfar, David S BaldwinAnnals of the New York Academy of Sciences|January 1, 1991
Role of transforming growth factor-beta 1 in regulation of hematopoiesisF W Ruscetti, S E Jacobsen, M Birchenall-Roberts, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 25, 2010
Constitutive androstane receptor -null mice are sensitive to the toxic effects of parathion: association with reduced cytochrome p450-mediated parathion metabolism [corrected]Linda C Mota, Juan P Hernandez, William S BaldwinHuman Psychopharmacology|August 14, 2015
Can cognitive behaviour therapy beneficially influence arousal mechanisms in psychosis?Fleur M Howells, David S Baldwin, David G KingdonData in Brief|March 14, 2022
Dataset of endo- and xenobiotic inhibition of CYP2B6: Comparison to CYP3A4Emily M Olack, Melissa M Heintz, William S BaldwinJournal of Molecular Biology|May 18, 1999
DNA cleavage by the EcoRV restriction endonuclease: pH dependence and proton transfers in catalysisN P Stanford, S E Halford, G S BaldwinMolecular and Cellular Biology|October 1, 1993
NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like moleculeR I Scheinman, A A Beg, A S BaldwinJournal of Biochemistry|June 1, 1996
A new inhibitor of mitochondrial fatty acid oxidationT Hashimoto, Y Shindo, M Souri, et al.Science (New York, N.Y.)|November 1, 1996
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaBC Y Wang, M W Mayo, A S BaldwinPageof 105